Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration

Clinical and Experimental Ophthalmology

Volumn 36, Issue 3, 2008, Pages 252-256

  Garg, Sunir ^a   Brod, Roy ^b   Kim, David ^c   Lane, R Gary ^c   Maguire, Joseph ^a   Fischer, David ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Roy Brod   (United States)

^c WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

Avastin; Bevacizumab; Macular degeneration; Retinal pigment epithelium; Tear

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB;

AGED; ARTICLE; CASE STUDY; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HUMAN; INCIDENCE; INTERVENTION STUDY; MALE; OUTCOMES RESEARCH; PIGMENT EPITHELIUM; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; RETINA TEAR; RETROSPECTIVE STUDY; RISK FACTOR; VISUAL ACUITY; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INCIDENCE; INJECTIONS; MACULAR DEGENERATION; MALE; PIGMENT EPITHELIUM OF EYE; RETINAL PERFORATIONS; RETROSPECTIVE STUDIES; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 42449095527     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2008.01710.x     Document Type: Article

References (32)

1. Hoskin A, Bird AC, Sehmi K. Tears of detached retinal pigment epithelium. Br J Ophthalmol 1981; 65: 417-22.
2. Gass JD. Pathogenesis of tears of the retinal pigment epithelium. Br J Ophthalmol 1984; 68: 513-19.
3. Decker WL, Sanborn GE, Ridley M et al. Retinal pigment epithelial tears. Ophthalmology 1983; 90: 507-12.
4. Gass JD. Retinal pigment epithelial rip during krypton red laser photocoagulation. Am J Ophthalmol 1984; 98: 700-6.
5. Pece A, Introini U, Bottoni F, Brancato R. Acute retinal pigment epithelial tear after photodynamic therapy. Retina 2001; 21: 661-5.
6. Gelisken F, Inhoffen W, Partsch M et al. Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization. Am J Ophthalmol 2001; 131: 518-20.
7. Dhalla MS, Blinder KJ, Tewari A et al. Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol 2006; 141: 752-4.
8. Nicolo M, Ghiglione D, Calabria G. Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin). Eur J Ophthalmol 2006; 16: 770-3.
9. Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU. Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration. Acta Ophthalmol Scand 2006; 84: 833-4.
10. Spandau UH, Jonas JB. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration. Am J Ophthalmol 2006; 142: 1068-70.
11. Shah CP, Hsu J, Garg SJ et al. Retinal pigment epithelial tear after intravitreal bevacizumab injection. Am J Ophthalmol 2006; 142: 1070-2.
12. Rosenfeld PJ, Brown DM, Heier JS et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1419-31.
13. Apte RS. Retinal pigment epithelial tear after intravitreal ranibizumab for subfoveal CNV secondary to AMD. Int Ophthalmol 2007; 27: 59-61.
14. Brown DM, Kaiser PK, Michels M et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1432-44.
15. Chan CK, Meyer CH, Gross JG et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Retina 2007; 27: 541-51.
16. Ronan SM, Yoganathan P, Chien FY et al. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 2007; 27: 535-40.
17. Chang LK, Sarraf D. Tears of the retinal pigment epithelium: An old problem a new era. Retina 2007; 27: 523-34.
18. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005; 36: 331-5.
19. Bashshur ZF, Bazarbachi A, Schakal A et al. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 2006; 142: 1-9.
20. Avery RL, Pieramici DJ, Rabena MD et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006; 113: 363-72. e5.
21. Ahmadieh H, Moradian S, Malihi M. Rapid regression of extensive retinovitreal neovascularization secondary to branch retinal vein occlusion after a single intravitreal injection of bevacizumab. Int Ophthalmol 2005; 26: 191-3.
22. Haritoglou C, Kook D, Neubauer A et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 2006; 26: 999-1005.
23. Isaacs TW, Barry C. Rapid resolution of severe disc new vessels in proliferative diabetic retinopathy following a single intravitreal injection of bevacizumab (Avastin). Clin Experiment Ophthalmol 2006; 34: 802-3.
24. Oshima Y, Sakaguchi H, Gomi F, Tano Y. Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol 2006; 142: 155-8.
25. Avery RL. Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina 2006; 26: 352-4.
26. Tewari A, Dhalla MS, Apte RS. Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia. Retina 2006; 26: 1093-4.
27. Chen E, Park CH. Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy. Retina 2006; 26: 699-700.
28. Carvounis PE, Kopel AC, Benz MS. Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration. Am J Ophthalmol 2007; 143: 504-5.
29. Bakri SJ, Kitzmann AS. Retinal pigment epithelial tear after intravitreal ranibizumab. Am J Ophthalmol 2007; 143: 505-7.
30. Bressler NM. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol 2001; 119: 198-207.
31. Barbazetto I, Burdan A, Bressler NM et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: Fluorescein angiographic guidelines for evaluation and treatment -TAP and VIP report No. 2. Arch Ophthalmol 2003; 121: 1253-68.
32. Pece A, Isola V, Vadala M, Calori G. Photodynamic therapy with verteporfin for choroidal neovascularization associated with retinal pigment epithelial detachment in age-related macular degeneration. Retina 2007; 27: 342-8.